Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of MBX Biosciences Inc (NASDAQ: MBX) was $17.96 for the day, up 2.98% from the previous closing price of $17.44. In other words, the price has increased by $2.98 from its previous closing price. On the day, 0.81 million shares were traded. MBX stock price reached its highest trading level at $18.735 during the session, while it also had its lowest trading level at $16.9501.
Ratios:
Our analysis of MBX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 19.50 and its Current Ratio is at 19.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Truist on October 15, 2025, initiated with a Buy rating and assigned the stock a target price of $50.
On August 05, 2025, Mizuho started tracking the stock assigning a Outperform rating and target price of $38.Mizuho initiated its Outperform rating on August 05, 2025, with a $38 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 20 ’25 when Hawryluk P. Kent bought 20,000 shares for $13.64 per share. The transaction valued at 272,790 led to the insider holds 468,277 shares of the business.
Hoerter Steven L. bought 20,000 shares of MBX for $264,984 on Oct 17 ’25. The Director now owns 20,000 shares after completing the transaction at $13.25 per share. On Sep 26 ’25, another insider, Heron Patrick J, who serves as the Director of the company, bought 666,666 shares for $18.00 each. As a result, the insider paid 11,999,988 and bolstered with 5,219,440 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBX now has a Market Capitalization of 803090240 and an Enterprise Value of 379089824.
Stock Price History:
The Beta on a monthly basis for MBX is 1.05, which has changed by -0.21653187 over the last 52 weeks, in comparison to a change of 0.18258524 over the same period for the S&P500. Over the past 52 weeks, MBX has reached a high of $27.50, while it has fallen to a 52-week low of $4.81. The 50-Day Moving Average of the stock is 23.53%, while the 200-Day Moving Average is calculated to be 53.66%.
Shares Statistics:
MBX traded an average of 1.20M shares per day over the past three months and 916990 shares per day over the past ten days. A total of 33.59M shares are outstanding, with a floating share count of 26.70M. Insiders hold about 40.30% of the company’s shares, while institutions hold 48.66% stake in the company. Shares short for MBX as of 1760486400 were 3909541 with a Short Ratio of 3.25, compared to 1757894400 on 4226517. Therefore, it implies a Short% of Shares Outstanding of 3909541 and a Short% of Float of 14.01.
Earnings Estimates
The company has 5.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.66, with high estimates of -$0.54 and low estimates of -$0.82.
Analysts are recommending an EPS of between -$2.31 and -$2.9 for the fiscal current year, implying an average EPS of -$2.6. EPS for the following year is -$2.51, with 6.0 analysts recommending between -$2.21 and -$2.78.
